Pain Management Drugs and Devices - Global Market Outlook (2016-2022)
According to Stratistics MRC, the Global Pain Management Drugs and Devices market is expected to grow from $39.48 billion in 2015 to reach $58.2 billion by 2022 with a CAGR of 5.7%. Growing various pain disorders coupled with increasing global geriatric people is the major factor propelling the pain management drugs and devices market. Furthermore, rapid technological developments, growing healthcare industry across the globe are some of the factors boosting the market growth. However, intensified competition between companies and lack of skilled professionals are the factors inhibiting the market growth.
The Neuromodulation device leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing chronic back pain. By drugs, opiods segment commands the market accounting for more than 42% of the total market. North America is anticipated to hold the largest share in global pain management drugs and devices market due to increasing demand from U.S. and Asia Pacific is likely to grow at a fastest rate during the forecast period.
Some of the key players in global pain management drugs and devices market include Abbvie Inc., Astrazeneca Depomed Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Eli Lilly & Co., Glaxosmithkline, Halyard Health, Inc., Hisamitsu Pharmaceutical Co. Inc, Johnson & Johnson, Medtronic Inc., Medtronic PLC, Neurotech Na, Inc. (A Subsidiary of Theragen LLC), Nevro Corp., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Smiths Medical, and ST. Jude Medical, Inc.
Drug Classes Covered:
The Neuromodulation device leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing chronic back pain. By drugs, opiods segment commands the market accounting for more than 42% of the total market. North America is anticipated to hold the largest share in global pain management drugs and devices market due to increasing demand from U.S. and Asia Pacific is likely to grow at a fastest rate during the forecast period.
Some of the key players in global pain management drugs and devices market include Abbvie Inc., Astrazeneca Depomed Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Eli Lilly & Co., Glaxosmithkline, Halyard Health, Inc., Hisamitsu Pharmaceutical Co. Inc, Johnson & Johnson, Medtronic Inc., Medtronic PLC, Neurotech Na, Inc. (A Subsidiary of Theragen LLC), Nevro Corp., Novartis International Ag, Pfizer, Purdue Pharmaceuticals Lp, Smiths Medical, and ST. Jude Medical, Inc.
Drug Classes Covered:
- Anti-Migraine Agents
- Non-Narcotic Analgesics
- Opioids
- NSAIDS
- Anesthetics
- Anticovulsants
- Antidepressent
- Analgesic Infusion Pumps
- External Infusion Pumps
- Intrathecal Infusion Pumps
- Ablation Devices
- Cryoablation Devices
- Radiofrequency Ablation Devices
- Electrical stimulation devices
- Neuromuscular Electrical Stimulation (NMES/EMS) Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Other Electrical Stimulation Devices
- Neuromodulation Devices
- Sacral Nerve Stimulation Devices
- Deep Brain Stimulation Devices
- Vagus Nerve Stimulation Devices
- Spinal Cord Stimulation (SCS) Devices
- Arthritic pain
- Cancer pain
- Migraine
- Fibromyalgia
- Chronic back pain
- Neuropathic pain
- Post-operative pain
- Cancer Pain
- Facial Pain and Migraine
- Musculoskeletal Pain
- Neuropathic Pain
- Other Applications
- Post-operative Pain
- Pregnancy/Labor and Menstrual Pain
- Sports Injuries
- Trauma Pain
- Prescription-based Devices
- Over-the-counter Devices
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DRUG CLASS
5.1 Introduction
5.2 Anti-Migraine Agents
5.3 Non-Narcotic Analgesics
5.4 Opioids
5.5 NSAIDS
5.6 Anesthetics
5.7 Anticovulsants
5.8 Antidepressent
6 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DEVICE TYPE
6.1 Introduction
6.2 Analgesic Infusion Pumps
6.2.1 External Infusion Pumps
6.2.2 Intrathecal Infusion Pumps
6.3 Ablation Devices
6.3.1 Cryoablation Devices
6.3.2 Radiofrequency Ablation Devices
6.4 Electrical stimulation devices
6.4.1 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
6.4.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.4.3 Other Electrical Stimulation Devices
6.4.3.1 Combination Devices
6.4.3.2 TMS
6.4.3.3 Electrotherapy Devices
6.4.3.4 TNS
6.5 Neuromodulation Devices
6.5.1 Sacral Nerve Stimulation Devices
6.5.2 Deep Brain Stimulation Devices
6.5.3 Vagus Nerve Stimulation Devices
6.5.4 Spinal Cord Stimulation (SCS) Devices
7 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY INDICATIONS
7.1 Introduction
7.2 Arthritic pain
7.3 Cancer pain
7.4 Migraine
7.5 Fibromyalgia
7.6 Chronic back pain
7.7 Neuropathic pain
7.8 Post-operative pain
8 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY APPLICATION
8.1 Introduction
8.2 Cancer Pain
8.3 Facial Pain and Migraine
8.4 Musculoskeletal Pain
8.5 Neuropathic Pain
8.6 Other Applications
8.6.1 Post-operative Pain
8.6.2 Pregnancy/Labor and Menstrual Pain
8.6.3 Sports Injuries
8.6.4 Trauma Pain
9 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY MODE OF PURCHASE
9.1 Introduction
9.2 Prescription-based Devices
9.3 Over-the-counter Devices
10 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Abbvie Inc.
12.2 Astrazeneca Depomed Inc.
12.3 B. Braun Melsungen AG
12.4 Becton, Dickinson and Company
12.5 Boston Scientific Corporation
12.6 Eli Lilly & Co.
12.7 Glaxosmithkline
12.8 Halyard Health, Inc.
12.9 Hisamitsu Pharmaceutical Co. Inc
12.10 Johnson & Johnson
12.11 Medtronic Inc.
12.12 Medtronic PLC
12.13 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
12.14 Nevro Corp.
12.15 Novartis International Ag
12.16 Pfizer
12.17 Purdue Pharmaceuticals Lp
12.18 Smiths Medical
12.19 ST. Jude Medical, Inc.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DRUG CLASS
5.1 Introduction
5.2 Anti-Migraine Agents
5.3 Non-Narcotic Analgesics
5.4 Opioids
5.5 NSAIDS
5.6 Anesthetics
5.7 Anticovulsants
5.8 Antidepressent
6 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY DEVICE TYPE
6.1 Introduction
6.2 Analgesic Infusion Pumps
6.2.1 External Infusion Pumps
6.2.2 Intrathecal Infusion Pumps
6.3 Ablation Devices
6.3.1 Cryoablation Devices
6.3.2 Radiofrequency Ablation Devices
6.4 Electrical stimulation devices
6.4.1 Neuromuscular Electrical Stimulation (NMES/EMS) Devices
6.4.2 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
6.4.3 Other Electrical Stimulation Devices
6.4.3.1 Combination Devices
6.4.3.2 TMS
6.4.3.3 Electrotherapy Devices
6.4.3.4 TNS
6.5 Neuromodulation Devices
6.5.1 Sacral Nerve Stimulation Devices
6.5.2 Deep Brain Stimulation Devices
6.5.3 Vagus Nerve Stimulation Devices
6.5.4 Spinal Cord Stimulation (SCS) Devices
7 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY INDICATIONS
7.1 Introduction
7.2 Arthritic pain
7.3 Cancer pain
7.4 Migraine
7.5 Fibromyalgia
7.6 Chronic back pain
7.7 Neuropathic pain
7.8 Post-operative pain
8 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY APPLICATION
8.1 Introduction
8.2 Cancer Pain
8.3 Facial Pain and Migraine
8.4 Musculoskeletal Pain
8.5 Neuropathic Pain
8.6 Other Applications
8.6.1 Post-operative Pain
8.6.2 Pregnancy/Labor and Menstrual Pain
8.6.3 Sports Injuries
8.6.4 Trauma Pain
9 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY MODE OF PURCHASE
9.1 Introduction
9.2 Prescription-based Devices
9.3 Over-the-counter Devices
10 GLOBAL PAIN MANAGEMENT DRUGS AND DEVICES MARKET, BY GEOGRAPHY
10.1 North America
10.1.1 US
10.1.2 Canada
10.1.3 Mexico
10.2 Europe
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 UK
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia Pacific
10.3.1 Japan
10.3.2 China
10.3.3 India
10.3.4 Australia
10.3.5 New Zealand
10.3.6 Rest of Asia Pacific
10.4 Rest of the World
10.4.1 Middle East
10.4.2 Brazil
10.4.3 Argentina
10.4.4 South Africa
10.4.5 Egypt
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Abbvie Inc.
12.2 Astrazeneca Depomed Inc.
12.3 B. Braun Melsungen AG
12.4 Becton, Dickinson and Company
12.5 Boston Scientific Corporation
12.6 Eli Lilly & Co.
12.7 Glaxosmithkline
12.8 Halyard Health, Inc.
12.9 Hisamitsu Pharmaceutical Co. Inc
12.10 Johnson & Johnson
12.11 Medtronic Inc.
12.12 Medtronic PLC
12.13 Neurotech Na, Inc. (A Subsidiary of Theragen LLC)
12.14 Nevro Corp.
12.15 Novartis International Ag
12.16 Pfizer
12.17 Purdue Pharmaceuticals Lp
12.18 Smiths Medical
12.19 ST. Jude Medical, Inc.
LIST OF TABLES
1 Global Pain Management Drugs and Devices Market, By Region (2013-2022) ($MN)
2 Global Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
3 Global Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
4 Global Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
5 Global Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
6 Global Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
7 Global Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
8 Global Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
9 Global Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
10 Global Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
11 Global Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
12 Global Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
13 Global Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
14 Global Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
15 Global Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
16 Global Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
17 Global Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
18 Global Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
19 Global Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
20 Global Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
21 Global Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
22 Global Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
23 Global Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
24 Global Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
25 Global Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
26 Global Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
27 Global Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
28 Global Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
29 Global Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
30 Global Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
31 Global Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
32 Global Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
33 Global Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
34 Global Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
35 Global Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
36 Global Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
37 Global Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
38 Global Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
39 Global Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
40 Global Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
41 Global Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
42 Global Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
43 Global Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
44 Global Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
45 Global Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
46 Global Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
47 North America Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
48 North America Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
49 North America Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
50 North America Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
51 North America Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
52 North America Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
53 North America Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
54 North America Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
55 North America Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
56 North America Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
57 North America Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
58 North America Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
59 North America Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
60 North America Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
61 North America Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
62 North America Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
63 North America Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
64 North America Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
65 North America Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
66 North America Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
67 North America Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
68 North America Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
69 North America Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
70 North America Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
71 North America Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
72 North America Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
73 North America Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
74 North America Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
75 North America Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
76 North America Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
77 North America Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
78 North America Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
79 North America Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
80 North America Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
81 North America Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
82 North America Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
83 North America Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
84 North America Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
85 North America Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
86 North America Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
87 North America Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
88 North America Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
89 North America Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
90 North America Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
91 North America Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
92 North America Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
93 Europe Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
94 Europe Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
95 Europe Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
96 Europe Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
97 Europe Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
98 Europe Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
99 Europe Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
100 Europe Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
101 Europe Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
102 Europe Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
103 Europe Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
104 Europe Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
105 Europe Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
106 Europe Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
107 Europe Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
108 Europe Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
109 Europe Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
110 Europe Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
111 Europe Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
112 Europe Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
113 Europe Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
114 Europe Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
115 Europe Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
116 Europe Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
117 Europe Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
118 Europe Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
119 Europe Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
120 Europe Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
121 Europe Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
122 Europe Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
123 Europe Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
124 Europe Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
125 Europe Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
126 Europe Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
127 Europe Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
128 Europe Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
129 Europe Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
130 Europe Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
131 Europe Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
132 Europe Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
133 Europe Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
134 Europe Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
135 Europe Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
136 Europe Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
137 Europe Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
138 Europe Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
139 Asia Pacific Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
140 Asia Pacific Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
141 Asia Pacific Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
142 Asia Pacific Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
143 Asia Pacific Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
144 Asia Pacific Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
145 Asia Pacific Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
146 Asia Pacific Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
147 Asia Pacific Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
148 Asia Pacific Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
149 Asia Pacific Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
150 Asia Pacific Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
151 Asia Pacific Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
152 Asia Pacific Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
153 Asia Pacific Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
154 Asia Pacific Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
155 Asia Pacific Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
156 Asia Pacific Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
157 Asia Pacific Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
158 Asia Pacific Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
159 Asia Pacific Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
160 Asia Pacific Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
161 Asia Pacific Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
162 Asia Pacific Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
163 Asia Pacific Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
164 Asia Pacific Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
165 Asia Pacific Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
166 Asia Pacific Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
167 Asia Pacific Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
168 Asia Pacific Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
169 Asia Pacific Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
170 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
171 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
172 Asia Pacific Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
173 Asia Pacific Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
174 Asia Pacific Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
175 Asia Pacific Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
176 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
177 Asia Pacific Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
178 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
179 Asia Pacific Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
180 Asia Pacific Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
181 Asia Pacific Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
182 Asia Pacific Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
183 Asia Pacific Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
184 Asia Pacific Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
185 RoW Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
186 RoW Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
187 RoW Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
188 RoW Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
189 RoW Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
190 RoW Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
191 RoW Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
192 RoW Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
193 RoW Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
194 RoW Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
195 RoW Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
196 RoW Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
197 RoW Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
198 RoW Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
199 RoW Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
200 RoW Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
201 RoW Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
202 RoW Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
203 RoW Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
204 RoW Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
205 RoW Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
206 RoW Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
207 RoW Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
208 RoW Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
209 RoW Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
210 RoW Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
211 RoW Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
212 RoW Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
213 RoW Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
214 RoW Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
215 RoW Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
216 RoW Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
217 RoW Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
218 RoW Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
219 RoW Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
220 RoW Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
221 RoW Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
222 RoW Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
223 RoW Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
224 RoW Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
225 RoW Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
226 RoW Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
227 RoW Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
228 RoW Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
229 RoW Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
230 RoW Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
1 Global Pain Management Drugs and Devices Market, By Region (2013-2022) ($MN)
2 Global Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
3 Global Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
4 Global Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
5 Global Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
6 Global Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
7 Global Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
8 Global Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
9 Global Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
10 Global Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
11 Global Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
12 Global Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
13 Global Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
14 Global Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
15 Global Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
16 Global Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
17 Global Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
18 Global Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
19 Global Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
20 Global Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
21 Global Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
22 Global Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
23 Global Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
24 Global Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
25 Global Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
26 Global Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
27 Global Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
28 Global Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
29 Global Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
30 Global Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
31 Global Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
32 Global Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
33 Global Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
34 Global Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
35 Global Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
36 Global Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
37 Global Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
38 Global Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
39 Global Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
40 Global Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
41 Global Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
42 Global Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
43 Global Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
44 Global Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
45 Global Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
46 Global Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
47 North America Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
48 North America Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
49 North America Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
50 North America Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
51 North America Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
52 North America Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
53 North America Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
54 North America Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
55 North America Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
56 North America Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
57 North America Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
58 North America Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
59 North America Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
60 North America Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
61 North America Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
62 North America Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
63 North America Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
64 North America Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
65 North America Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
66 North America Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
67 North America Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
68 North America Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
69 North America Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
70 North America Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
71 North America Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
72 North America Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
73 North America Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
74 North America Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
75 North America Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
76 North America Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
77 North America Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
78 North America Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
79 North America Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
80 North America Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
81 North America Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
82 North America Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
83 North America Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
84 North America Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
85 North America Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
86 North America Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
87 North America Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
88 North America Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
89 North America Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
90 North America Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
91 North America Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
92 North America Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
93 Europe Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
94 Europe Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
95 Europe Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
96 Europe Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
97 Europe Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
98 Europe Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
99 Europe Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
100 Europe Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
101 Europe Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
102 Europe Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
103 Europe Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
104 Europe Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
105 Europe Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
106 Europe Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
107 Europe Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
108 Europe Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
109 Europe Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
110 Europe Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
111 Europe Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
112 Europe Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
113 Europe Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
114 Europe Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
115 Europe Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
116 Europe Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
117 Europe Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
118 Europe Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
119 Europe Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
120 Europe Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
121 Europe Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
122 Europe Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
123 Europe Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
124 Europe Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
125 Europe Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
126 Europe Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
127 Europe Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
128 Europe Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
129 Europe Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
130 Europe Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
131 Europe Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
132 Europe Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
133 Europe Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
134 Europe Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
135 Europe Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
136 Europe Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
137 Europe Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
138 Europe Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
139 Asia Pacific Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
140 Asia Pacific Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
141 Asia Pacific Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
142 Asia Pacific Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
143 Asia Pacific Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
144 Asia Pacific Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
145 Asia Pacific Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
146 Asia Pacific Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
147 Asia Pacific Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
148 Asia Pacific Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
149 Asia Pacific Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
150 Asia Pacific Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
151 Asia Pacific Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
152 Asia Pacific Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
153 Asia Pacific Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
154 Asia Pacific Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
155 Asia Pacific Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
156 Asia Pacific Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
157 Asia Pacific Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
158 Asia Pacific Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
159 Asia Pacific Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
160 Asia Pacific Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
161 Asia Pacific Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
162 Asia Pacific Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
163 Asia Pacific Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
164 Asia Pacific Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
165 Asia Pacific Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
166 Asia Pacific Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
167 Asia Pacific Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
168 Asia Pacific Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
169 Asia Pacific Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
170 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
171 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
172 Asia Pacific Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
173 Asia Pacific Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
174 Asia Pacific Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
175 Asia Pacific Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
176 Asia Pacific Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
177 Asia Pacific Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
178 Asia Pacific Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
179 Asia Pacific Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
180 Asia Pacific Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
181 Asia Pacific Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
182 Asia Pacific Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
183 Asia Pacific Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
184 Asia Pacific Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
185 RoW Pain Management Drugs and Devices Market, By Country (2013-2022) ($MN)
186 RoW Pain Management Drugs and Devices Market, By Drug Class (2013-2022) ($MN)
187 RoW Pain Management Drugs and Devices Market, By Anti-Migraine Agents (2013-2022) ($MN)
188 RoW Pain Management Drugs and Devices Market, By Non-Narcotic Analgesics (2013-2022) ($MN)
189 RoW Pain Management Drugs and Devices Market, By Opioids (2013-2022) ($MN)
190 RoW Pain Management Drugs and Devices Market, By NSAIDS (2013-2022) ($MN)
191 RoW Pain Management Drugs and Devices Market, By Anesthetics (2013-2022) ($MN)
192 RoW Pain Management Drugs and Devices Market, By Anticovulsants (2013-2022) ($MN)
193 RoW Pain Management Drugs and Devices Market, By Antidepressent (2013-2022) ($MN)
194 RoW Pain Management Drugs and Devices Market, By Device Type (2013-2022) ($MN)
195 RoW Pain Management Drugs and Devices Market, By Analgesic Infusion Pumps (2013-2022) ($MN)
196 RoW Pain Management Drugs and Devices Market, By External Infusion Pumps (2013-2022) ($MN)
197 RoW Pain Management Drugs and Devices Market, By Intrathecal Infusion Pumps (2013-2022) ($MN)
198 RoW Pain Management Drugs and Devices Market, By Ablation Devices (2013-2022) ($MN)
199 RoW Pain Management Drugs and Devices Market, By Cryoablation Devices (2013-2022) ($MN)
200 RoW Pain Management Drugs and Devices Market, By Radiofrequency Ablation Devices (2013-2022) ($MN)
201 RoW Pain Management Drugs and Devices Market, By Electrical stimulation devices (2013-2022) ($MN)
202 RoW Pain Management Drugs and Devices Market, By Neuromuscular Electrical Stimulation (NMES/EMS) Devices (2013-2022) ($MN)
203 RoW Pain Management Drugs and Devices Market, By Transcutaneous Electrical Nerve Stimulation (TENS) Devices (2013-2022) ($MN)
204 RoW Pain Management Drugs and Devices Market, By Other Electrical Stimulation Devices (2013-2022) ($MN)
205 RoW Pain Management Drugs and Devices Market, By Neuromodulation Devices (2013-2022) ($MN)
206 RoW Pain Management Drugs and Devices Market, By Sacral Nerve Stimulation Devices (2013-2022) ($MN)
207 RoW Pain Management Drugs and Devices Market, By Deep Brain Stimulation Devices (2013-2022) ($MN)
208 RoW Pain Management Drugs and Devices Market, By Vagus Nerve Stimulation Devices (2013-2022) ($MN)
209 RoW Pain Management Drugs and Devices Market, By Spinal Cord Stimulation (SCS) Devices (2013-2022) ($MN)
210 RoW Pain Management Drugs and Devices Market, By Indications (2013-2022) ($MN)
211 RoW Pain Management Drugs and Devices Market, By Arthritic pain (2013-2022) ($MN)
212 RoW Pain Management Drugs and Devices Market, By Cancer pain (2013-2022) ($MN)
213 RoW Pain Management Drugs and Devices Market, By Migraine (2013-2022) ($MN)
214 RoW Pain Management Drugs and Devices Market, By Fibromyalgia (2013-2022) ($MN)
215 RoW Pain Management Drugs and Devices Market, By Chronic back pain (2013-2022) ($MN)
216 RoW Pain Management Drugs and Devices Market, By Neuropathic pain (2013-2022) ($MN)
217 RoW Pain Management Drugs and Devices Market, By Post-operative pain (2013-2022) ($MN)
218 RoW Pain Management Drugs and Devices Market, By Application (2013-2022) ($MN)
219 RoW Pain Management Drugs and Devices Market, By Cancer Pain (2013-2022) ($MN)
220 RoW Pain Management Drugs and Devices Market, By Facial Pain and Migraine (2013-2022) ($MN)
221 RoW Pain Management Drugs and Devices Market, By Musculoskeletal Pain (2013-2022) ($MN)
222 RoW Pain Management Drugs and Devices Market, By Neuropathic Pain (2013-2022) ($MN)
223 RoW Pain Management Drugs and Devices Market, By Other Applications (2013-2022) ($MN)
224 RoW Pain Management Drugs and Devices Market, By Post-operative Pain (2013-2022) ($MN)
225 RoW Pain Management Drugs and Devices Market, By Pregnancy/Labor and Menstrual Pain (2013-2022) ($MN)
226 RoW Pain Management Drugs and Devices Market, By Sports Injuries (2013-2022) ($MN)
227 RoW Pain Management Drugs and Devices Market, By Trauma Pain (2013-2022) ($MN)
228 RoW Pain Management Drugs and Devices Market, By Mode of Purchase (2013-2022) ($MN)
229 RoW Pain Management Drugs and Devices Market, By Prescription-based Devices (2013-2022) ($MN)
230 RoW Pain Management Drugs and Devices Market, By Over-the-counter Devices (2013-2022) ($MN)
